Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen-specific cellular immune responses

Journal of Medical Virology

Volumn 79, Issue 5, 2007, Pages 522-529

  Ochoa Callejero, Laura ^a   Berraondo, Pedro ^c   Crettaz, Julien ^a   Olagüe, Cristina ^a   Vales, África ^a   Ruiz, Juan ^d   Prieto, Jesús ^a   Tennant, Bud C ^b   Menne, Stephan ^b   González Aseguinolaza, Gloria ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Department of Obstetrics Gynecology   (United States)

^c INSTITUT PASTEUR   (France)

^d Digna Biotech   (Spain)

Author keywords

Adenovirus; HBV; Monocyte derived dendritic cells; Vaccine; Woodchuck

Indexed keywords

BETA GALACTOSIDASE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELLULAR IMMUNITY; DENDRITIC CELL; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEPATITIS VIRUS; HUMAN; HUMAN ADENOVIRUS 5; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PROTEIN EXPRESSION; VIRUS RECOMBINANT; WOODCHUCK;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD86; BETA-GALACTOSIDASE; CELL DIVISION; CELLS, CULTURED; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HEPATITIS B, CHRONIC; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNIZATION SCHEDULE; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTES; MARMOTA; REASSORTANT VIRUSES; SPECIES SPECIFICITY; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA; HEPATITIS B VIRUS; HUMAN ADENOVIRUS; MARMOTA MONAX; WOODCHUCK HEPATITIS VIRUS;

EID: 34147190306     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20808     Document Type: Article

References (52)

1. Akbar SM, Horiike N, Onji M, Hino 0.2001. Dendritic cells and chronic hepatitis virus carriers. Intervirology 44:199-208.
2. Banchereau J, Steinman EM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
3. Barratt-Boyes SM, Henderson RA, Finn OJ. 1996. Chimpanzee dendritic cells with potent immunostimulatory function can be propagated from peripheral blood. Immunology 87:528-534.
4. Bienzle D, Reggeti F, Clark ME, Chow C. 2003. Immunophenotype and functional properties of feline dendritic cells derived from blood and bone marrow. Vet Immunol Immunopathol 96:19-30.
5. Bourinbaiar AS, Root-Bernstein RS, Abulafia-Lapid R, Rytik PG, Kanev AN, Jirathitikal V, Orlovsky VG. 2006. Therapeutic AIDS vaccines. Curr Pharm Des 12:2017-2030.
6. Catchpole B, Stell AJ, Dobson JM. 2002. Generation of blood-derived dendritic cells in dogs with oral malignant melanoma. J Comp Pathol 126:238-241.
7. Chen M, Li YG, Zhang DZ, Wang ZY, Zeng WQ, Shi XF, Guo Y, Guo SH, Ren H. 2005. Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: A clinical study. World J Gastroenterol 11:1806-1808.
8. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60.
9. Conti L, Fantuzzi L, Del Corno M, Belardelli F, Gessani S. 2004. Immunomodulatory effects of the HIV-1 gp120 protein on antigen presenting cells: Implications for AIDS pathogenesis. Immunobiology 209:99-115.
10. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS. 2004. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 24:637-646.
11. Duan XZ, Zhuang H, Wang M, Li HW, Liu JC, Wang FS. 2005. Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2). J Gastroenterol Hepatol 20:234-242.
12. Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, Yuen T, Sealfon SC, Garcia-Sastre A, Moran TM. 2006. Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 80:6295-6304.
13. Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, Petit MA, Fiaccadori F. 1990. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 145:3442-3449.
14. Garcia-Navarro R, Blanco-Urgoiti B, Berraondo P, Sanchez de la Rosa R, Vales A, Hervas-Stubbs S, Lasarte JJ, Borras F, Ruiz J, Prieto J. 2001. Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12. J Virol 75:9068-9076.
15. Gautherot I, Burdin N, Seguin D, Aujame L, Sodoyer R. 2002. Cloning of interleukin-4 delta2 splice variant (IL-4delta2) in chimpanzee and cynomolgus macaque: Phylogenetic analysis of delta2 splice variant appearance, and implications for the study of IL-4-driven immune processes. Immunogenetics 54:635-644.
16. Hammond SA, Horohov D, Montelaro RC. 1999. Functional characterization of equine dendritic cells propagated ex vivo using recombinant human GM-CSF and recombinant equine IL-4. Vet Immunol Immunopathol 71:197-214.
17. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. 1997. Construction of adenovirus vectors through Cre-lox recombination. J Virol 71:1842-1849.
18. Horiike N, Md Fazle Akbar S, Ninomiya T, Abe M, Michitaka K, Onji M. 2002. Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus. Hepatol Res 23:38-47.
19. Jenne L, Thumarin P, Steinkasserer A. 2001. Interaction of large DNA viruses with dendritic cells. Immunobiology 204:639-648.
20. Kikuchi T. 2006. Genetically modified dendritic cells for therapeutic immunity. Tohoku J Exp Med 208:1-8.
21. Kubba AK, Taylor P, Graneek B, Strobel S. 2003. Non-responders to hepatitis B vaccination: A review. Commun Dis Public Health 6:106-112.
22. Ludewig B. 2003. Dendritic cell vaccination and viral infection-Animal models. Curr Top Microbiol Immunol 276:199-214.
23. Markiewicz MA, Kast WM. 2004. Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes. Cancer Invest 22:417-434.
24. Maschke J, Menne S, Jacob JR, Kreuzfelder E, Tennant BC, Roggendorf M, Grosse-Wilde H. 2001. Thymidine utilization abnormality in proliferating lymphocytes and hepatocytes of the woodchuck. Vet Immunol Immunopathol 78:279-296.
25. Meng WS, Butterfield LH. 2005. Activation of antigen-presenting cells by DNA delivery vectors. Expert Opin Biol Ther 5:1019-1028.
26. Menne S, Cote PJ. 2004. In: Robert K, Hamatake JYNL, editors. Hepatitis B and D Protocols. Totowa, NJ: Humana Press, pp 27-36.
27. Menne S, Maschke J, Tolle TK, Lu M, Roggendorf M. 1997. Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope. J Virol 71:65-74.
28. Novak N, Peng WM. 2005. Dancing with the enemy: The interplay of herpes simplex virus with dendritic cells. Clin Exp Immunol 142:405-410.
29. Nussenzweig MC, Steinman RM. 1980. Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction. J Exp Med 151:1196-1212.
30. Pollara G, Katz DR, Chain BM. 2005. LIGHTing up dendritic cell activation: Immune regulation and viral exploitation. J Cell Physiol 205:161-162.
31. Rivollier A, Mazzorana M, Tebib J, Piperno M, Aitsiselmi T, Rabourdin-Combe C, Jurdic P, Servet-Delprat C. 2004. Immature dendritic cell transdifferentiation into osteoclasts: A novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104:4029-4037.
32. Roggendorf M, Tolle TK. 1995. The woodchuck: An animal model for hepatitis B virus infection in man. Intervirology 38:100-112.
33. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G. 1994. Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83-93.
34. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109-1118.
35. Sarobe P, Lasarte JJ, Zabaleta A, Arribillaga L, Arina A, Melero I, Borras-Cuesta F, Prieto J. 2003. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol 77:10862-10871.
36. Schneider-Schaulies S, Klagge IM, ter Meulen V. 2003. Dendritic cells and measles virus infection. Curr Top Microbiol Immunol 276:77-101.
37. Srivastava PK. 2006. Therapeutic cancer vaccines. Curr Opin Immunol 18:201-205.
38. Steinman RM, Nussenzweig MC. 2002. Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99:351-358.
39. Szmuness W. 1979. Large-scale efficacy trials of hepatitis B vaccines in the USA: Baseline data and protocols. J Med Virol 4:327-340.
40. Tanimoto K, Akbar SM, Michitaka K, Horiike N, Onji M. 2001. Antigen-presenting cells at the liver tissue in patients with chronic viral liver diseases: CD83-positive mature dendritic cells at the vicinity of focal and confluent necrosis. Hepatol Res 21:117-125.
41. Tavakoli S, Schwerin W, Rohwer A, Hoffmann S, Weyer S, Weth R, Meisel H, Diepolder H, Geissler M, Galle PR, Lohr HF, Bocher WO. 2004. Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J Gen Virol 85:2829-2836.
42. Tennant BC. 2001. Animal models of hepadnavirus-associated hepatocellular carcinoma. Clin Liver Dis 5:43-68.
43. Tennant BC, Gerin JL. 2001. The woodchuck model of hepatitis B virus infection. Ilar J 42:89-102.
44. Tennant BC, Toshkov IA, Peek SF, Jacob JR, Menne S, Hornbuckle WE, Schinazi RD, Korba BE, Cote PJ, Gerin JL. 2004. Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection. Gastroenterology 127:8283-8293.
45. Villeneuve JP. 2005. The natural history of chronic hepatitis B virus infection. J Clin Virol 34 (Suppl 1):S139-S142.
46. Webster G, Bertoletti A. 2001. Quantity and quality of virus-specific CD8 cell response: Relevance to the design of a therapeutic vaccine for chronic HBV infection. Mol Immunol 38:467-473.
47. West KA, al-Alwan MM, Colp PE, Rowden G. 1999. Characterization of porcine dendritic cells grown in vitro. Transplant Proc 31:666-667.
48. Wu HL, Chen PJ, Lin HK, Lee RS, Lin HL, Liu CJ, Lee PJ, Lee JJ, Chen DS. 2001. Molecular cloning and expression of woodchuck granulocyte-macrophage colony stimulating factor. J Med Virol 65:567-575.
49. Wu Q, Xia D, Carlsen S, Xiang J. 2005. Adenovirus-mediated transgene-engineered dendritic cell vaccine of cancer. Curr Gene Ther 5:237-247.
50. Yalcin K, Danis R, Degertekin H, Alp MN, Tekes S, Budak T. 2003. The lack of effect of therapeutic vaccination with a pre-S2/S HBV vaccine in the immune tolerant phase of chronic HBV infection. J Clin Gastroenterol 37:330-335.
51. Yim HJ, Lok AS. 2006. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005. Hepatology 43:8173-8181.
52. Zhong L, Granelli-Piperno A, Choi Y, Steinman RM. 1999. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur J Immunol 29:964-972.